Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-24-000108
Filing Date
2024-07-19
Accepted
2024-07-19 16:56:42
Documents
1
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1721422595.html 4  
1 FORM 4 wk-form4_1721422595.xml 4 3870
  Complete submission text file 0001610618-24-000108.txt   5484
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 241128342

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)